Journal profile
Medicine Advances
ISSN 2834-4391 · eISSN 2834-4405 · Wiley · China · Quarterly · Founded 2023
Medicine Advances: impact factor 5.3 (journal website); fully open access; APC about USD 2,750; median 78 days to acceptance (82 articles, last 24 months); community-reported acceptance: 83%; 53 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Medicine Advances is published by Wiley. By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 28.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Medicine Advances is an open access general medical journal. This journal is dedicated to promoting the application of multidisciplinary integration in clinical disease diagnosis, treatment and medical research, emphasizing interdisciplinary collaboration, combining expertise from different fields, and exploring complex medical issues from multiple dimensions. Our goal is to bring together the latest scientific research progress and technological innovations from around the world, covering major breakthroughs in basic research, applied results in clinical research, the latest technological advances, and innovative cases of interdisciplinary collaboration. At the same time, we also focus on exploring and developing the practical significance of AI in the medical field, actively responding to the trend of the era of medical big data, and demonstrating the new style of scientific research in which cutting-edge computer technology is injected into and combined with the medical field. The aim of Medicine Advances is to provide an open academic forum for researchers, clinicians, public health experts and policy makers to promote knowledge transfer and sharing. By publishing high-quality academic papers and research findings, we hope to stimulate interdisciplinary collaboration and discussion, promote the translation of scientific discoveries into clinical applications through multidisciplinary synergies, enhance clinical practice, and address global health challenges. We are also committed to showcasing cutting-edge technologies and innovations in the industry and supporting in-depth exploration of emerging trends, thereby promoting the overall development and advancement of the medical field. Topics of particular interest include, but are not limited to the following: Basic Research on Diseases The purpose of this section is to share cutting-edge research findings on the underlying mechanisms and biological processes of diseases, including but not limited to etiologic studies, pathophysiologic studies, molecular biology studies, animal model studies, and animal and tissue studies; Clinical Research on Diseases The purpose of this section is to share the results of the application of basic research in the clinical setting, including but not limited to clinical trials, epidemiological studies, diagnostic modalities and testing of diseases, therapeutic research and customization of personalized treatment plans, and prognostic research and management; Innovative Ad
From the journal's Aims & Scope
Editor-in-chief Xueqing YuPublisher website
Editorial board by country: 72 in mainland China (about 49%); most named Mainland China 72, United States 28, Hong Kong, China 11, Singapore 8, Australia 7 (147 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance9.5%
- Human auditory perception and evaluationEngineering9.5%
- Educational Robotics and EngineeringComputer Science9.5%
- Artificial Intelligence in Healthcare and EducationMedicine7.4%
- Lung Cancer Treatments and MutationsMedicine6.1%
- Machine Learning in HealthcareComputer Science5.4%
- Ferroptosis and cancer prognosisMedicine4.7%
- Radiomics and Machine Learning in Medical ImagingMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5.3Publisher website ·
- Impact factor (publisher) 2025
- 5.3Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- CiteScore (publisher)
- 3.3Publisher website ·
- CiteScore (publisher) 2025
- 3.3Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.96LetPub ·
- h-index
- 16OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 3.27OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 31LetPub ·
- Articles per year (publisher) 2025
- 45Publisher website ·
- Downloads per year (publisher) 2025
- 65,379Publisher website ·
Articles by year OpenAlex count · 185 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 14 |
| 2025 | 53 | 53 | 136 |
| 2024 | 46 | 46 | 304 |
| 2023 | 46 | 46 | 397 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
78 daysMedian, submission to acceptance · P25–P75 49 days – 125 days
- Acceptance to online
- median 121 days (82 articles)
- Submission to online
- median 215 days
- Sample
- 82 articles with submission and acceptance dates (91 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Average acceptance (community reports)
- 83%LetPub ·
- Acceptance rate (publisher)
- 36%Publisher website ·
- Acceptance rate (publisher) 2025
- 36%Publisher website ·
- Submission to first decision
- 18 daysPublisher website ·
- Submission to first decision 2025
- 18 daysPublisher website ·
- Submission to final decision
- 48 daysPublisher website ·
- Submission to acceptance 2025
- 71 daysPublisher website ·
- Acceptance to publication 2025
- 93 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,750 / GBP 1,850 / EUR 2,500 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| LetPub | EUR 2,500 / GBP 1,850 / USD 2,750 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- reviewDescription: Reviews are summaries of recent insights in specific research areas within the scope of the journal.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, License & copyright, Open access, Peer review
- AI use
AI guidelines apply from 1 April 2025. Model summary
From 1st April 2025, all submissions and reviews must adhere to Generative artificial intelligence (AI) guidelines. Note: Medicine Advances adopts Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics – Artificial Intelligence.
Source ↗Publisher website ·- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing expected. Model summary
This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley's Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access Understanding Open Access
As an open access journal, all articles in Medicine Advances are freely available to read, download and share immediately on publication. Learn more about open access:
Source ↗Publisher website ·- Peer review Peer-Review Metrics
Single-anonymized peer review; at least two anonymous reviewers. Model summary
Submission to first decision: 25 Submission to final decision: 48 Submission to acceptance: 52
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- China
- Language
- English
- Frequency
- Quarterly
- Founded
- 2023
- ISSN
- 2834-4391
- Electronic ISSN
- 2834-4405
- Society / sponsor
- Guangdong Academy of Medical Sciences
- Latest issue on the website
- Volume 4, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Medicine Advances
What is the impact factor of Medicine Advances?
The journal's website gives an impact factor of 5.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.3, h-index 16.
How long does peer review take at Medicine Advances?
Based on the dates recorded on 82 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 49–125 days); authors report an average review time of about 8 weeks; the community-reported acceptance is “83%”; the journal's website gives an acceptance rate of 36% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Medicine Advances based?
Of the 147 board members whose country the journal's board page names, 72 (about 49%) are in mainland China; the countries named most often are Mainland China (72), United States (28) and Hong Kong, China (11). Counted from the institutions listed on the board page; for reference only.
Which databases index Medicine Advances?
According to LetPub and DOAJ records, Medicine Advances is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and CAS; that list has not been checked against each database.
Is Medicine Advances open access, and what is the APC?
Medicine Advances is a fully open-access journal. APC about USD 2,750.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .